Skip to main content

Published locations for Obinutuzumab provides strong early responses in untreated MCL

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Obinutuzumab provides strong early responses in untreated MCL

User login

  • Reset your password
  • /content/obinutuzumab-provides-strong-early-responses-untreated-mcl
  • /hematologynews/article/203069/mantle-cell-lymphoma/obinutuzumab-provides-strong-early-responses
  • /hematology-oncology/article/203069/mantle-cell-lymphoma/obinutuzumab-provides-strong-early-responses
  • /hematologytimes/article/203069/mantle-cell-lymphoma/obinutuzumab-provides-strong-early-responses
  • /b-cell-lymphoma-icymi/article/203069/mantle-cell-lymphoma/obinutuzumab-provides-strong-early